Carillon Tower Advisers’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding RGEN
FAM
1WCM
Carillon Tower Advisers's RGEN Position: Q4 2020 in Review
Carillon Tower Advisers increased its Repligen (RGEN) stake by 68% in Q4 2020, buying an estimated $26M and bringing the position to 354,554 shares worth $67.9M. The position accounts for 0.41% of the portfolio, ranked #74.
Carillon Tower Advisers first reported a position in RGEN in Q2 2019 and has held it in 7 quarters since. 449 funds tracked by Wall St. Rank hold RGEN as of Q4 2020.
- Carillon Tower Advisers held 354,554 shares of Repligen worth $67.9M as of Q4 2020.
- Carillon Tower Advisers bought 143,171 Repligen shares in Q4 2020, an estimated $26M.
- Repligen made up 0.41% of Carillon Tower Advisers's portfolio in Q4 2020, its #74 holding.
- Carillon Tower Advisers first reported a position in Repligen in Q2 2019 and has held it in 7 quarters since.
- 449 funds tracked by Wall St. Rank held Repligen as of Q4 2020.
Based on Carillon Tower Advisers's 13F filing for Q4 2020, filed 12 Feb 2021.